In a tie-up with US generic drugmaker Mylan NV, the Bengaluru-based biopharmaceutical firm has five biosimilar products – almost identical copies of original drugs – entering global regulatory approval stage which is expected to take about 18-20 months.
| Subscribe To Our Free Newsletter |
